Static Chart Agilent Technologies, Inc.

Stocks

Market Closed - NYSE Other stock markets 04:00:03 2026-07-17 pm EDT			5-day change	1st Jan Change
131.46 ^USD	-3.41%		-2.11%	-3.39%

Jul. 14	Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma	CI
Jul. 14	Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers	MT

Duration

Period